To understand the effects of the TYROBP deletion in myeloid lineage cells, we obtained monocytes from NHD patients with biallelic TYROBP deletion (hereafter referred to as NHD), monoallelic TYROBP deletion carriers, and control individuals (Fig. 5A). Here, TYROBP is linked to Nasu-Hakola disease.